| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 149.28B | 165.62B | 151.16B | 149.17B | 142.65B | 134.09B |
| Gross Profit | 33.64B | 38.78B | 33.31B | 29.22B | 31.27B | 25.91B |
| EBITDA | 14.65B | 17.42B | 15.47B | 12.03B | 14.95B | 10.89B |
| Net Income | 9.37B | 13.73B | 10.39B | 8.76B | 9.62B | 7.43B |
Balance Sheet | ||||||
| Total Assets | 175.19B | 190.47B | 196.41B | 191.18B | 179.69B | 174.53B |
| Cash, Cash Equivalents and Short-Term Investments | 61.53B | 40.33B | 39.43B | 45.34B | 65.24B | 42.98B |
| Total Debt | 1.16B | 849.00M | 12.12B | 800.00M | 288.00M | 396.00M |
| Total Liabilities | 69.22B | 76.89B | 86.84B | 80.18B | 78.52B | 80.18B |
| Stockholders Equity | 105.02B | 112.56B | 108.73B | 110.34B | 100.60B | 93.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 23.54B | -6.37B | -17.23B | 26.38B | 7.49B |
| Operating Cash Flow | 0.00 | 24.66B | -4.07B | -12.22B | 32.19B | 9.00B |
| Investing Cash Flow | 0.00 | -1.74B | 1.26B | -8.44B | -5.60B | -2.39B |
| Financing Cash Flow | 0.00 | -25.77B | 938.00M | -3.38B | -4.28B | -9.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥240.03B | 18.20 | 9.02% | 3.11% | 9.57% | 40.16% | |
75 Outperform | ¥993.32B | 60.50 | 6.61% | 1.58% | -1.47% | -19.46% | |
74 Outperform | ¥81.09B | 10.90 | 16.37% | 2.79% | 42.29% | 55.00% | |
73 Outperform | ¥715.64B | 24.82 | ― | 1.43% | 8.81% | 17.58% | |
64 Neutral | ¥141.90B | 15.69 | 12.54% | 1.84% | 17.17% | 33.30% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥218.76B | 20.35 | ― | 2.41% | 5.68% | -49.64% |